<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39408347</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Tryptophan Metabolism Disorder-Triggered Diseases, Mechanisms, and Therapeutic Strategies: A Scientometric Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3380</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16193380</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tryptophan is widely present in foods such as peanuts, milk, and bananas, playing a crucial role in maintaining metabolic homeostasis in health and disease. Tryptophan metabolism is involved in the development and progression of immune, nervous, and digestive system diseases. Although some excellent reviews on tryptophan metabolism exist, there has been no systematic scientometric study as of yet.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This review provides and summarizes research hotspots and potential future directions by analyzing annual publications, topics, keywords, and highly cited papers sourced from Web of Science spanning 1964 to 2022.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This review provides a scientometric overview of tryptophan metabolism disorder-triggered diseases, mechanisms, and therapeutic strategies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The gut microbiota regulates gut permeability, inflammation, and host immunity by directly converting tryptophan to indole and its derivatives. Gut microbial metabolites regulate tryptophan metabolism by activating specific receptors or enzymes. Additionally, the kynurenine (KYN) pathway, activated by indoleamine-2, 3-dioxygenase (IDO) and tryptophan 2, 3-dioxygenase, affects the migration and invasion of glioma cells and the development of COVID-19 and depression. The research and development of IDO inhibitors help to improve the effectiveness of immunotherapy. Tryptophan metabolites as potential markers are used for disease therapy, guiding clinical decision-making. Tryptophan metabolites serve as targets to provide a new promising strategy for neuroprotective/neurotoxic imbalance affecting brain structure and function. In summary, this review provides valuable guidance for the basic research and clinical application of tryptophan metabolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Dong</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8871-9006</Identifier><AffiliationInfo><Affiliation>Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xu-Jiao</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yuan-Lu</ForeName><Initials>YL</Initials><Identifier Source="ORCID">0000-0003-4392-3713</Identifier><AffiliationInfo><Affiliation>Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Component-Based Chinese Medicine, Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 22HHZYSS00001</GrantID><Agency>Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050503">Indoleamine-Pyrrole 2,3,-Dioxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>343-65-7</RegistryNumber><NameOfSubstance UI="D007737">Kynurenine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="Y">Tryptophan</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="N">Bibliometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050503" MajorTopicYN="N">Indoleamine-Pyrrole 2,3,-Dioxygenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007737" MajorTopicYN="N">Kynurenine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">scientometric analysis</Keyword><Keyword MajorTopicYN="N">tryptophan metabolism</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408347</ArticleId><ArticleId IdType="pmc">PMC11478743</ArticleId><ArticleId IdType="doi">10.3390/nu16193380</ArticleId><ArticleId IdType="pii">nu16193380</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tanaka M., Toth F., Polyak H., Szabo A., Mandi Y., Vecsei L. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines. 2021;9:734. doi: 10.3390/biomedicines9070734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9070734</ArticleId><ArticleId IdType="pmc">PMC8301407</ArticleId><ArticleId IdType="pubmed">34202246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglund E., Overli O., Winberg S. Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review. Front. Endocrinol. 2019;10:158. doi: 10.3389/fendo.2019.00158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00158</ArticleId><ArticleId IdType="pmc">PMC6463810</ArticleId><ArticleId IdType="pubmed">31024440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Zhu S.W., Ma N., Johnston L.J., Wu C.D., Ma X. Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation. Med. Res. Rev. 2021;41:1061–1088. doi: 10.1002/med.21752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21752</ArticleId><ArticleId IdType="pubmed">33174230</ArticleId></ArticleIdList></Reference><Reference><Citation>Modoux M., Rolhion N., Mani S., Sokol H. Tryptophan Metabolism as a Pharmacological Target. Trends Pharmacol. Sci. 2021;42:60–73. doi: 10.1016/j.tips.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.11.006</ArticleId><ArticleId IdType="pubmed">33256987</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Li G., Zheng Q., Gu X., Shi Q., Su Y., Chu Q., Yuan X., Bao Z., Lu J., et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35:1304–1326. doi: 10.1016/j.cmet.2023.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2023.06.004</ArticleId><ArticleId IdType="pubmed">37352864</ArticleId></ArticleIdList></Reference><Reference><Citation>Platten M., Nollen E.A.A., Rohrig U.F., Fallarino F., Opitz C.A. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat. Rev. Drug Discov. 2019;18:379–401. doi: 10.1038/s41573-019-0016-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0016-5</ArticleId><ArticleId IdType="pubmed">30760888</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagenais-Lussier X., Loucif H., Beji C., Telittchenko R., Routy J.P., van Grevenynghe J. Latest developments in tryptophan metabolism: Understanding its role in B cell immunity. Cytokine Growth Factor Rev. 2021;59:111–117. doi: 10.1016/j.cytogfr.2021.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.02.003</ArticleId><ArticleId IdType="pubmed">33658144</ArticleId></ArticleIdList></Reference><Reference><Citation>Donthu N., Kumar S., Mukherjee D., Pandey N., Lim W.M. How to conduct a bibliometric analysis: An overview and guidelines. J. Bus. Res. 2021;133:285–296. doi: 10.1016/j.jbusres.2021.04.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbusres.2021.04.070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y.T., Li Y.J., Zhang Z.H., Gu Z.C., Zhong H., Zha Q.F., Yang L.Y., Zhu C., Chen E.Z. A bibliometric analysis using VOSviewer of publications on COVID-19. Ann. Transl. Med. 2020;8:13. doi: 10.21037/atm-20-4235.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-4235</ArticleId><ArticleId IdType="pmc">PMC7396244</ArticleId><ArticleId IdType="pubmed">32793661</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Wang Y.L., Wang K.T., Wang Y., Dong X.R., Tang J., Cui Y.L. A Scientometrics Analysis and Visualization of Depressive Disorder. Curr. Neuropharmacol. 2021;19:766–786. doi: 10.2174/1570159X18666200905151333.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X18666200905151333</ArticleId><ArticleId IdType="pmc">PMC8686305</ArticleId><ArticleId IdType="pubmed">32888272</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G., Jin B., Xian X.M., Yang H.Y., Zhao H.T., Du S.D., Makuuchi M., Pawlik T.M., Mao Y.L. Evolutions in the Management of Hepatocellular Carcinoma over Last 4 Decades: An Analysis from the 100 Most Influential Articles in the Field. Liver Cancer. 2021;10:137–150. doi: 10.1159/000513412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513412</ArticleId><ArticleId IdType="pmc">PMC8077437</ArticleId><ArticleId IdType="pubmed">33977090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W.X., Xu D., Zhao L., Yuan M.M., Cui Y.L., Li Y. Therapeutic role of curcumin in adult neurogenesis for management of psychiatric and neurological disorders: A scientometric study to an in-depth review. Crit. Rev. Food Sci. Nutr. 2022;63:9379–9391. doi: 10.1080/10408398.2022.2067827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2067827</ArticleId><ArticleId IdType="pubmed">35482938</ArticleId></ArticleIdList></Reference><Reference><Citation>Aria M., Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J. Informetr. 2017;11:959–975. doi: 10.1016/j.joi.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joi.2017.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson W. The metabolism of tryptophan. III. The mode of formation of kynurenic acid from tryptophan. Biochem. J. 1928;22:1165–1168. doi: 10.1042/bj0221165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj0221165</ArticleId><ArticleId IdType="pmc">PMC1252237</ArticleId><ArticleId IdType="pubmed">16744114</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson W. The metabolism of tryptophan. II. Synthesis of 6-methyl- and 8-methylkynurenic acids. Biochem. J. 1928;22:1157–1164. doi: 10.1042/bj0221157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj0221157</ArticleId><ArticleId IdType="pmc">PMC1252236</ArticleId><ArticleId IdType="pubmed">16744113</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H.N., Lee P.C. Mapping knowledge structure by keyword co-occurrence: A first look at journal papers in Technology Foresight. Scientometrics. 2010;85:65–79. doi: 10.1007/s11192-010-0259-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-010-0259-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.N., Fang R.Y., Liu Z.H., Jiang L.P., Zhang J.D., Li H.H., Liu C.Y., Li F. The association between toxic pesticide environmental exposure and Alzheimer’s disease: A scientometric and visualization analysis. Chemosphere. 2021;263:128238. doi: 10.1016/j.chemosphere.2020.128238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2020.128238</ArticleId><ArticleId IdType="pubmed">33297185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H.Y., Tong L.J., Wang Y.L., Yan H., Sun Z.M. Bibliometric Analysis of Global Research Trends on Ultrasound Microbubble: A Quickly Developing Field. Front. Pharmacol. 2021;12:646626. doi: 10.3389/fphar.2021.646626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.646626</ArticleId><ArticleId IdType="pmc">PMC8101552</ArticleId><ArticleId IdType="pubmed">33967783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamas B., Richard M.L., Leducq V., Pham H.P., Michel M.L., Da Costa G., Bridonneau C., Jegou S., Hoffmann T.W., Natividad J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 2016;22:598–605. doi: 10.1038/nm.4102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4102</ArticleId><ArticleId IdType="pmc">PMC5087285</ArticleId><ArticleId IdType="pubmed">27158904</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaus S., Schulte B., Al-Massad N., Thieme F., Schulte D.M., Bethge J., Rehman A., Tran F., Aden K., Hasler R., et al. Increased Tryptophan Metabolism Is Associated with Activity of Inflammatory Bowel Diseases. Gastroenterology. 2017;153:1504–1516. doi: 10.1053/j.gastro.2017.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.08.028</ArticleId><ArticleId IdType="pubmed">28827067</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubeva A.V., Joyce S.A., Moloney G., Burokas A., Sherwin E., Arboleya S., Flynn I., Khochanskiy D., Moya-Perez A., Peterson V., et al. Microbiota-related Changes in Bile Acid &amp; Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism. eBioMedicine. 2017;24:166–178. doi: 10.1016/j.ebiom.2017.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.09.020</ArticleId><ArticleId IdType="pmc">PMC5652137</ArticleId><ArticleId IdType="pubmed">28965876</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich M., Sankowski R., Bunse L., Kilian M., Green E., Guevara C.R., Pusch S., Poschet G., Sanghvi K., Hahn M., et al. Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas. Nat. Cancer. 2021;2:723–740. doi: 10.1038/s43018-021-00201-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43018-021-00201-z</ArticleId><ArticleId IdType="pubmed">35121943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrzosek L., Ciocan D., Hugot C., Spatz M., Dupeux M., Houron C., Lievin-Le Moal V., Puchois V., Ferrere G., Trainel N., et al. Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury. Gut. 2021;70:1299–1308. doi: 10.1136/gutjnl-2020-321565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321565</ArticleId><ArticleId IdType="pubmed">33004548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.Q., Ren D.Y., Zhao Y., Liu L., Yang X.B. Fuzhuan Brick Tea Polysaccharide Improved Ulcerative Colitis in Association with Gut Microbiota-Derived Tryptophan Metabolism. J. Agric. Food Chem. 2021;69:8448–8459. doi: 10.1021/acs.jafc.1c02774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.1c02774</ArticleId><ArticleId IdType="pubmed">34313113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.J., Mu X.H., Cao Q.N., Shi Y., Hu X.S., Zheng H. Honeybee gut Lactobacillus modulates host learning and memory behaviors via regulating tryptophan metabolism. Nat. Commun. 2022;13:2037. doi: 10.1038/s41467-022-29760-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29760-0</ArticleId><ArticleId IdType="pmc">PMC9018956</ArticleId><ArticleId IdType="pubmed">35440638</ArticleId></ArticleIdList></Reference><Reference><Citation>Agus A., Planchais J., Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018;23:716–724. doi: 10.1016/j.chom.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.05.003</ArticleId><ArticleId IdType="pubmed">29902437</ArticleId></ArticleIdList></Reference><Reference><Citation>Benech N., Rolhion N., Sokol H. Gut Microbiota Reprogramming of Tryptophan Metabolism during Pregnancy Shapes Host Insulin Resistance. Gastroenterology. 2022;162:1587–1589. doi: 10.1053/j.gastro.2022.01.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.01.059</ArticleId><ArticleId IdType="pubmed">35247461</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudzinska E., Szymona K., Kloc R., Gil-Kulik P., Kocki T., Swistowska M., Bogucki J., Kocki J., Urbanska E.M. Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease. Ther. Adv. Gastroenterol. 2019;12:1756284819881304. doi: 10.1177/1756284819881304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756284819881304</ArticleId><ArticleId IdType="pmc">PMC6801885</ArticleId><ArticleId IdType="pubmed">31666808</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaudel C., Danne C., Agus A., Magniez A., Aucouturier A., Spatz M., Lefevre A., Kirchgesner J., Rolhion N., Wang Y.Z., et al. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut. 2022;72:1296–1307. doi: 10.1136/gutjnl-2022-327337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-327337</ArticleId><ArticleId IdType="pmc">PMC10314090</ArticleId><ArticleId IdType="pubmed">36270778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofia M.A., Ciorba M.A., Meckel K., Lim C.K., Guillemin G.J., Weber C.R., Bissonnette M., Pekow J.R. Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis. Inflamm. Bowel Dis. 2018;24:1471–1480. doi: 10.1093/ibd/izy103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izy103</ArticleId><ArticleId IdType="pmc">PMC6196764</ArticleId><ArticleId IdType="pubmed">29796641</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiering C., Wincent E., Metidji A., Iseppon A., Li Y., Potocnik A.J., Omenetti S., Henderson C.J., Wolf C.R., Neberts D.W., et al. Feedback control of AHR signalling regulates intestinal immunity. Nature. 2017;542:242–245. doi: 10.1038/nature21080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21080</ArticleId><ArticleId IdType="pmc">PMC5302159</ArticleId><ArticleId IdType="pubmed">28146477</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., Scott K., Stanton C., Swanson K.S., Cani P.D., et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017;14:491–502. doi: 10.1038/nrgastro.2017.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.75</ArticleId><ArticleId IdType="pubmed">28611480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy P.J., Cryan J.F., Dinan T.G., Clarke G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology. 2017;112:399–412. doi: 10.1016/j.neuropharm.2016.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.07.002</ArticleId><ArticleId IdType="pubmed">27392632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemos H., Huang L., Prendergast G.C., Mellor A.L. Immune control by amino acid catabolism during tumorigenesis and therapy. Nat. Rev. Cancer. 2019;19:162–175. doi: 10.1038/s41568-019-0106-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-019-0106-z</ArticleId><ArticleId IdType="pubmed">30696923</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochez L., Meireson A., Chevolet I., Sundahl N., Ost P., Kruse V. Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma. Nat. Commun. 2018;9:2921. doi: 10.1038/s41467-018-05047-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05047-1</ArticleId><ArticleId IdType="pmc">PMC6062523</ArticleId><ArticleId IdType="pubmed">30050132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C.K., Fernández-Gomez F.J., Braidy N., Estrada C., Costa C., Costa S., Bessede A., Fernandez-Villalba E., Zinger A., Herrero M.T., et al. Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s disease. Prog. Neurobiol. 2017;155:76–95. doi: 10.1016/j.pneurobio.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.12.009</ArticleId><ArticleId IdType="pubmed">27072742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chini C.C.S., Zeidler J.D., Kashyap S., Warner G., Chini E.N. Evolving concepts in NAD(+) metabolism. Cell Metab. 2021;33:1076–1087. doi: 10.1016/j.cmet.2021.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8172449</ArticleId><ArticleId IdType="pubmed">33930322</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins T.A., Nguyen J.C.D., Polglaze K.E., Bertrand P.P. Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients. 2016;8:56. doi: 10.3390/nu8010056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8010056</ArticleId><ArticleId IdType="pmc">PMC4728667</ArticleId><ArticleId IdType="pubmed">26805875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawe G.M., Hoffman J.M. Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2013;10:473–486. doi: 10.1038/nrgastro.2013.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2013.105</ArticleId><ArticleId IdType="pmc">PMC4048923</ArticleId><ArticleId IdType="pubmed">23797870</ArticleId></ArticleIdList></Reference><Reference><Citation>Herr N., Bode C., Duerschmied D. The Effects of Serotonin in Immune Cells. Front. Cardiovasc. Med. 2017;4:48. doi: 10.3389/fcvm.2017.00048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2017.00048</ArticleId><ArticleId IdType="pmc">PMC5517399</ArticleId><ArticleId IdType="pubmed">28775986</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayamohanan H., Kumar M.K.M., Aneesh T.P. 5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders. Adv. Pharm. Bull. 2019;9:374–381. doi: 10.15171/apb.2019.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/apb.2019.044</ArticleId><ArticleId IdType="pmc">PMC6773935</ArticleId><ArticleId IdType="pubmed">31592064</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudsen C., Neyrinck A.M., Leyrolle Q., Baldin P., Leclercq S., Rodriguez J., Beaumont M., Cani P.D., Bindels L.B., Lanthier N., et al. Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice. J. Nutr. 2021;151:1507–1516. doi: 10.1093/jn/nxab032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxab032</ArticleId><ArticleId IdType="pmc">PMC8169809</ArticleId><ArticleId IdType="pubmed">33693866</ArticleId></ArticleIdList></Reference><Reference><Citation>Serger E., Luengo-Gutierrez L., Chadwick J.S., Kong G.P., Zhou L.M., Crawford G., Danzi M.C., Myridakis A., Brandis A., Bello A.T., et al. The gut metabolite indole-3 propionate promotes nerve regeneration and repair. Nature. 2022;607:585–592. doi: 10.1038/s41586-022-04884-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04884-x</ArticleId><ArticleId IdType="pubmed">35732737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadik A., Patterson L.F.S., Ozturk S., Mohapatra S.R., Panitz V., Secker P.F., Pfander P., Loth S., Salem H., Prentzell M.T., et al. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression. Cell. 2020;182:1252–1270. doi: 10.1016/j.cell.2020.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.038</ArticleId><ArticleId IdType="pubmed">32818467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L.S., Davies S.S. Microbial metabolism of dietary components to bioactive metabolites: Opportunities for new therapeutic interventions. Genome Med. 2016;8:46. doi: 10.1186/s13073-016-0296-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0296-x</ArticleId><ArticleId IdType="pmc">PMC4840492</ArticleId><ArticleId IdType="pubmed">27102537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjögren K., Engdahl C., Henning P., Lerner U.H., Tremaroli V., Lagerquist M.K., Bäckhed F., Ohlsson C. The gut microbiota regulates bone mass in mice. J. bone Miner. Res. 2012;27:1357–1367. doi: 10.1002/jbmr.1588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.1588</ArticleId><ArticleId IdType="pmc">PMC3415623</ArticleId><ArticleId IdType="pubmed">22407806</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA. 2009;106:3698–3703. doi: 10.1073/pnas.0812874106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812874106</ArticleId><ArticleId IdType="pmc">PMC2656143</ArticleId><ArticleId IdType="pubmed">19234110</ArticleId></ArticleIdList></Reference><Reference><Citation>Reigstad C.S., Salmonson C.E., Rainey J.F., Szurszewski J.H., Linden D.R., Sonnenburg J.L., Farrugia G., Kashyap P.C. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. Faseb J. 2015;29:1395–1403. doi: 10.1096/fj.14-259598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.14-259598</ArticleId><ArticleId IdType="pmc">PMC4396604</ArticleId><ArticleId IdType="pubmed">25550456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao K., Mu C.L., Farzi A., Zhu W.Y. Tryptophan Metabolism: A Link between the Gut Microbiota and Brain. Adv. Nutr. 2020;11:709–723. doi: 10.1093/advances/nmz127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz127</ArticleId><ArticleId IdType="pmc">PMC7231603</ArticleId><ArticleId IdType="pubmed">31825083</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahanonda R., Sa-Ard-Iam N., Montreekachon P., Pimkhaokham A., Yongvanichit K., Fukuda M.M., Pichyangkul S. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J. Immunol. 2007;178:1151–1157. doi: 10.4049/jimmunol.178.2.1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.2.1151</ArticleId><ArticleId IdType="pubmed">17202379</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh H.S., Zhao M.L., Rivieccio M., Choi S., Connolly E., Zhao Y., Takikawa O., Brosnan C.F., Lee S.C. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand Poly(I:C):: Mechanism of induction and role in antiviral response. J. Virol. 2007;81:9838–9850. doi: 10.1128/JVI.00792-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00792-07</ArticleId><ArticleId IdType="pmc">PMC2045380</ArticleId><ArticleId IdType="pubmed">17626075</ArticleId></ArticleIdList></Reference><Reference><Citation>Vujkovic-Cvijin I., Dunham R.M., Iwai S., Maher M.C., Albright R.G., Broadhurst M.J., Hernandez R.D., Lederman M.M., Huang Y., Somsouk M., et al. Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism. Sci. Transl. Med. 2013;5:193ra91. doi: 10.1126/scitranslmed.3006438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3006438</ArticleId><ArticleId IdType="pmc">PMC4094294</ArticleId><ArticleId IdType="pubmed">23843452</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Mahony S.M., Clarke G., Borre Y.E., Dinan T.G., Cryan J.F. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 2015;277:32–48. doi: 10.1016/j.bbr.2014.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2014.07.027</ArticleId><ArticleId IdType="pubmed">25078296</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervenka I., Agudelo L.Z., Ruas J.L. Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health. Science. 2017;357:eaaf9794. doi: 10.1126/science.aaf9794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf9794</ArticleId><ArticleId IdType="pubmed">28751584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L.S., Wu Q.F., Li K.L., Khan M.A.S., Zhang A.D., Sinha B., Li S.H., Chang S.L., Brody D.L., Grinstaff M.W., et al. Tryptophan Metabolism in Alzheimer’s Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis. Aging Dis. 2024;15:2168–2190. doi: 10.14336/AD.2024.0134.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2024.0134</ArticleId><ArticleId IdType="pmc">PMC11346405</ArticleId><ArticleId IdType="pubmed">38916729</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L.H., Bae M., Cassilly C.D., Jabba S.V., Thorpe D.W., Martin A.M., Lu H.Y., Wang J.H., Thompson J.D., Lickwar C.R., et al. Enteroendocrine cells sense bacterial tryptophan catabolites to activate enteric and vagal neuronal pathways. Cell Host Microbe. 2021;29:179–196. doi: 10.1016/j.chom.2020.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.011</ArticleId><ArticleId IdType="pmc">PMC7997396</ArticleId><ArticleId IdType="pubmed">33352109</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaglin M., Rhimi M., Philippe C., Pons N., Bruneau A., Goustard B., Daugé V., Maguin E., Naudon L., Rabot S. Indole, a Signaling Molecule Produced by the Gut Microbiota, Negatively Impacts Emotional Behaviors in Rats. Front. Neurosci. 2018;12:216. doi: 10.3389/fnins.2018.00216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00216</ArticleId><ArticleId IdType="pmc">PMC5900047</ArticleId><ArticleId IdType="pubmed">29686603</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennis M., Cavanaugh C.R., Leo G.C., Mabus J.R., Lenhard J., Hornby P.J. Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo. Neurogastroenterol. Motil. 2018;30:e13178. doi: 10.1111/nmo.13178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13178</ArticleId><ArticleId IdType="pubmed">28782205</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangoni A.A., Zinellu A. A systematic review and meta-analysis of the kynurenine pathway of tryptophan metabolism in rheumatic diseases. Front. Immunol. 2023;14:1257159. doi: 10.3389/fimmu.2023.1257159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1257159</ArticleId><ArticleId IdType="pmc">PMC10626995</ArticleId><ArticleId IdType="pubmed">37936702</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S.K., Kwon B. Immune regulation through tryptophan metabolism. Exp. Mol. Med. 2023;55:1371–1379. doi: 10.1038/s12276-023-01028-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-023-01028-7</ArticleId><ArticleId IdType="pmc">PMC10394086</ArticleId><ArticleId IdType="pubmed">37394584</ArticleId></ArticleIdList></Reference><Reference><Citation>Platten M., Friedrich M., Wainwright D.A., Panitz V., Opitz C.A. Tryptophan metabolism in brain tumors-IDO and beyond. Curr. Opin. Immunol. 2021;70:57–66. doi: 10.1016/j.coi.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC8373719</ArticleId><ArticleId IdType="pubmed">33813026</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Lu J., Du W.B. Tryptophan metabolism in digestive system tumors: Unraveling the pathways and implications. Cell Commun. Signal. 2024;22:174. doi: 10.1186/s12964-024-01552-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-024-01552-7</ArticleId><ArticleId IdType="pmc">PMC10926624</ArticleId><ArticleId IdType="pubmed">38462620</ArticleId></ArticleIdList></Reference><Reference><Citation>Prompetchara E., Kettoy C., Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020;38:1–9. doi: 10.12932/ap-200220-0772.</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/ap-200220-0772</ArticleId><ArticleId IdType="pubmed">32105090</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita H., Yamamoto K. Tryptophan Metabolism and COVID-19-Induced Skeletal Muscle Damage: Is ACE2 a Key Regulator? Front. Nutr. 2022;9:868845. doi: 10.3389/fnut.2022.868845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.868845</ArticleId><ArticleId IdType="pmc">PMC9028463</ArticleId><ArticleId IdType="pubmed">35463998</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai R.D., Fan Y.D., Li Q.Y., Cui H.T., Liu H.Z., Wang Y., Gong B.Y., Han L., Zhang S., Bian Y.H. Traditional Chinese medicine:an important broad-spectrum anti-coronavirus treatment strategy on COVID-19 background? Tradit. Med. Res. 2022;7:19. doi: 10.53388/TMR20220330274.</Citation><ArticleIdList><ArticleId IdType="doi">10.53388/TMR20220330274</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wichai N., Wang J., Liu X., Yan H., Wang Y., Luo M., Zhou S., Wang K., Li L., et al. Regulation of innate and adaptive immunity using herbal medicine: Benefits for the COVID-19 vaccination. Acupunct. Herb. Med. 2022;2:196–206. doi: 10.1097/HM9.0000000000000046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HM9.0000000000000046</ArticleId><ArticleId IdType="pmc">PMC9746255</ArticleId><ArticleId IdType="pubmed">37808346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Hu X., Geng L., Li N., Chen Y., Zhang J., Yuan X., Huang L., Ba D., Lian J., et al. Multi-effective characteristics and advantages of acupuncture in COVID-19 treatment. Acupunct. Herb. Med. 2023;3:83–95. doi: 10.1097/HM9.0000000000000062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HM9.0000000000000062</ArticleId><ArticleId IdType="pmc">PMC10317192</ArticleId><ArticleId IdType="pubmed">37810368</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao G., Wang S., Wang R., Tan L., Ma S., He S., Fan G., Zhu Y., Lyu M. “Three medicines and three formulas” in COVID-19: From bench to bedside. Acupunct. Herb. Med. 2023;3:309–322. doi: 10.1097/HM9.0000000000000082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HM9.0000000000000082</ArticleId></ArticleIdList></Reference><Reference><Citation>Belladonna M.L., Orabona C. Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19. Front. Pharmacol. 2020;11:959. doi: 10.3389/fphar.2020.00959.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00959</ArticleId><ArticleId IdType="pmc">PMC7319082</ArticleId><ArticleId IdType="pubmed">32636755</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J.A., Nemkov T., Bertolone L., Francis R.O., Hudson K.E., Zimring J.C., Hansen K.C., Hod E.A., et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y.P., Kim D.J., Takahashi T., Broadhurst D.I., Yan H., Ma S.G., Rattray N.J.W., Casanovas-Massana A., Israelow B., Klein J., et al. Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci. Signal. 2021;14:eabf8483. doi: 10.1126/scisignal.abf8483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abf8483</ArticleId><ArticleId IdType="pmc">PMC8432948</ArticleId><ArticleId IdType="pubmed">34230210</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191–1193. doi: 10.1126/science.281.5380.1191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5380.1191</ArticleId><ArticleId IdType="pubmed">9712583</ArticleId></ArticleIdList></Reference><Reference><Citation>Campesato L.F., Budhu S., Tchaicha J., Weng C.H., Gigoux M., Cohen I.J., Redmond D., Mangarin L., Pourpe S., Liu C.L., et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat. Commun. 2020;11:4011. doi: 10.1038/s41467-020-17750-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17750-z</ArticleId><ArticleId IdType="pmc">PMC7419300</ArticleId><ArticleId IdType="pubmed">32782249</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy A.A. The kynurenine pathway of tryptophan metabolism: A neglected therapeutic target of COVID-19 pathophysiology and immunotherapy. Biosci. Rep. 2023;43:BSR20230595. doi: 10.1042/BSR20230595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20230595</ArticleId><ArticleId IdType="pmc">PMC10407158</ArticleId><ArticleId IdType="pubmed">37486805</ArticleId></ArticleIdList></Reference><Reference><Citation>Orabona C., Pallotta M.T., Grohmann U. Different Partners, Opposite Outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase. Mol. Med. 2012;18:834–842. doi: 10.2119/molmed.2012.00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2012.00029</ArticleId><ArticleId IdType="pmc">PMC3409287</ArticleId><ArticleId IdType="pubmed">22481272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondanelli G., Albini E., Pallotta M.T., Volpi C., Chatenoud L., Kuhn C., Fallarino F., Matino D., Belladonna M.L., Bianchi R., et al. The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. Front. Immunol. 2017;8:428. doi: 10.3389/fimmu.2017.00428.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00428</ArticleId><ArticleId IdType="pmc">PMC5390013</ArticleId><ArticleId IdType="pubmed">28450863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshi M., Saito K., Hara A., Taguchi A., Ohtaki H., Tanaka R., Fujigaki H., Osawa Y., Takemura M., Matsunami H., et al. The Absence of IDO Upregulates Type I IFN Production, Resulting in Suppression of Viral Replication in the Retrovirus-Infected Mouse. J. Immunol. 2010;185:3305–3312. doi: 10.4049/jimmunol.0901150.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901150</ArticleId><ArticleId IdType="pubmed">20693424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T., Horimoto H., Kameyama T., Hayakawa S., Yamato H., Dazai M., Takada A., Kida H., Bott D., Zhou A.C., et al. Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense. Nat. Immunol. 2016;17:687–694. doi: 10.1038/ni.3422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3422</ArticleId><ArticleId IdType="pubmed">27089381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrom Q.T., Cioffi G., Waite K., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018. Neuro-Oncology. 2021;23:iii1–iii105. doi: 10.1093/neuonc/noab200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/noab200</ArticleId><ArticleId IdType="pmc">PMC8491279</ArticleId><ArticleId IdType="pubmed">34608945</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Zhang H.K., Sun Q., Geng R.X., Yuan F.E., Liu B.H., Chen Q.X. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment. Front. Immunol. 2021;12:730289. doi: 10.3389/fimmu.2021.730289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.730289</ArticleId><ArticleId IdType="pmc">PMC8517402</ArticleId><ArticleId IdType="pubmed">34659216</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene L.I., Bruno T.C., Christenson J.L., D’Alessandro A., Culp-Hill R., Torkko K., Borges V.F., Slansky J.E., Richer J.K. A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. Mol. Cancer Res. 2019;17:131–139. doi: 10.1158/1541-7786.MCR-18-0362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-18-0362</ArticleId><ArticleId IdType="pmc">PMC6318037</ArticleId><ArticleId IdType="pubmed">30143553</ArticleId></ArticleIdList></Reference><Reference><Citation>DiNatale B.C., Murray I.A., Schroeder J.C., Flaveny C.A., Lahoti T.S., Laurenzana E.M., Omiecinski C.J., Perdew G.H. Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling. Toxicol. Sci. 2010;115:89–97. doi: 10.1093/toxsci/kfq024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfq024</ArticleId><ArticleId IdType="pmc">PMC2855350</ArticleId><ArticleId IdType="pubmed">20106948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.T., Kimura A., Nakahama T., Chinen I., Masuda K., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2010;107:19961–19966. doi: 10.1073/pnas.1014465107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014465107</ArticleId><ArticleId IdType="pmc">PMC2993339</ArticleId><ArticleId IdType="pubmed">21041655</ArticleId></ArticleIdList></Reference><Reference><Citation>Opitz C.A., Litzenburger U.M., Sahm F., Ott M., Tritschler I., Trump S., Schumacher T., Jestaedt L., Schrenk D., Weller M., et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011;478:197–203. doi: 10.1038/nature10491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10491</ArticleId><ArticleId IdType="pubmed">21976023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S.Y., Huang G.Y., Feng J., Li D., Wang K., Wang L., Wu Z., Wan H., Zhang L.W., Zhang J.T. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. J. Neuro-Oncol. 2019;144:11–20. doi: 10.1007/s11060-019-03198-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-019-03198-9</ArticleId><ArticleId IdType="pubmed">31177425</ArticleId></ArticleIdList></Reference><Reference><Citation>Guastellal A.R., Michelhaugh S.K., Klinger N.V., Fadel H.A., Kiousis S., Ali-Fehmi R., Kupsky W.J., Juhasz C., Mittal S. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J. Neuro-Oncol. 2018;139:239–249. doi: 10.1007/s11060-018-2869-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-018-2869-6</ArticleId><ArticleId IdType="pmc">PMC6092214</ArticleId><ArticleId IdType="pubmed">29667084</ArticleId></ArticleIdList></Reference><Reference><Citation>Theate I., van Baren N., Pilotte L., Moulin P., Larrieu P., Renauld J.C., Herve C., Gutierrez-Roelens I., Marbaix E., Sempoux C., et al. Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues. Cancer Immunol. Res. 2015;3:161–172. doi: 10.1158/2326-6066.CIR-14-0137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-14-0137</ArticleId><ArticleId IdType="pubmed">25271151</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong C.H., Peng L.L., Tao B., Yin S.L., Lyu L., Ding H., Yang X.B., Peng T.M., He H.P., Zhou P.Z. TDO2 and tryptophan metabolites promote kynurenine/AhR signals to facilitate glioma progression and immunosuppression. Am. J. Cancer Res. 2022;12:2558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9251687</ArticleId><ArticleId IdType="pubmed">35812057</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L.S., Xing Z.K., Tao B.B., Li T.Q., Yang D., Li W.R., Zheng Y.T., Kuang C.X., Yang Q. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway. Signal Transduct. Target. Ther. 2020;5:10. doi: 10.1038/s41392-019-0103-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-019-0103-4</ArticleId><ArticleId IdType="pmc">PMC7033114</ArticleId><ArticleId IdType="pubmed">32296044</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.L., Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 2003;4:1206–1212. doi: 10.1038/ni1003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1003</ArticleId><ArticleId IdType="pubmed">14578884</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezrich J.D., Fechner J.H., Zhang X.J., Johnson B.P., Burlingham W.J., Bradfield C.A. An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells. J. Immunol. 2010;185:3190–3198. doi: 10.4049/jimmunol.0903670.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903670</ArticleId><ArticleId IdType="pmc">PMC2952546</ArticleId><ArticleId IdType="pubmed">20720200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.X., Chen S.L., Wang Z.H., Li J.H., Yuan Y.B., Feng W.T., Li W.H., Chen M.A., Liu Y.H. Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma. Front. Pharmacol. 2022;13:1061597. doi: 10.3389/fphar.2022.1061597.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1061597</ArticleId><ArticleId IdType="pmc">PMC9663932</ArticleId><ArticleId IdType="pubmed">36386216</ArticleId></ArticleIdList></Reference><Reference><Citation>Commisso C., Davidson S.M., Soydaner-Azeloglu R.G., Parker S.J., Kamphorst J.J., Hackett S., Grabocka E., Nofal M., Drebin J.A., Thompson C.B., et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497:633–637. doi: 10.1038/nature12138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12138</ArticleId><ArticleId IdType="pmc">PMC3810415</ArticleId><ArticleId IdType="pubmed">23665962</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayers J.R., Torrence M.E., Danai L.V., Papagiannakopoulos T., Davidson S.M., Bauer M.R., Lau A.N., Ji B.W., Dixit P.D., Hosios A.M., et al. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science. 2016;353:1161–1165. doi: 10.1126/science.aaf5171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf5171</ArticleId><ArticleId IdType="pmc">PMC5245791</ArticleId><ArticleId IdType="pubmed">27609895</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerurkar L., Siebert S., McInnes I.B., Cavanagh J. Rheumatoid arthritis and depression: An inflammatory perspective. Lancet Psychiatry. 2019;6:164–173. doi: 10.1016/S2215-0366(18)30255-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(18)30255-4</ArticleId><ArticleId IdType="pubmed">30366684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisgaard T.H., Allin K.H., Keefer L., Ananthakrishnan A.N., Jess T. Depression and anxiety in inflammatory bowel disease: Epidemiology, mechanisms and treatment. Nat. Rev. Gastroenterol. Hepatol. 2022;19:717–726. doi: 10.1038/s41575-022-00634-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00634-6</ArticleId><ArticleId IdType="pubmed">35732730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Chen L., Lim G., Sung B., Wang S.X., McCabe M.F., Rusanescu G., Yang L.L., Tian Y.H., Mao J.R. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J. Clin. Investig. 2012;122:2940–2954. doi: 10.1172/JCI61884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI61884</ArticleId><ArticleId IdType="pmc">PMC3408737</ArticleId><ArticleId IdType="pubmed">22751107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson M.A., Parrott J.M., McCusker R.H., Dantzer R., Kelley K.W., O’Connor J.C. Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J. Neuroinflammation. 2013;10:87. doi: 10.1186/1742-2094-10-87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-87</ArticleId><ArticleId IdType="pmc">PMC3733827</ArticleId><ArticleId IdType="pubmed">23866724</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y.J., Wang N.X., Zhang X.L., Han X.M., Zhai X.J., Lu Y.N. IDO and TDO as a potential therapeutic target in different types of depression. Metab. Brain Dis. 2018;33:1787–1800. doi: 10.1007/s11011-018-0290-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-018-0290-7</ArticleId><ArticleId IdType="pubmed">30014175</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Connor J.C., Andre C., Wang Y.X., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and Tumor Necrosis Factor-alpha Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin. J. Neurosci. 2009;29:4200–4209. doi: 10.1523/JNEUROSCI.5032-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5032-08.2009</ArticleId><ArticleId IdType="pmc">PMC2835569</ArticleId><ArticleId IdType="pubmed">19339614</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura H., Ozaki N., Sawada M., Isobe K., Ohta T., Nagatsu T. A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008;11:198–209. doi: 10.1080/10253890701754068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890701754068</ArticleId><ArticleId IdType="pubmed">18465467</ArticleId></ArticleIdList></Reference><Reference><Citation>Laumet G., Zhou W.J., Dantzer R., Edralin J.D., Huo X.J., Budac D.P., O’Connor J.C., Lee A.W., Heijnen C.J., Kavelaars A. Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain. Brain Behav. Immun. 2017;66:94–102. doi: 10.1016/j.bbi.2017.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.07.008</ArticleId><ArticleId IdType="pmc">PMC5650931</ArticleId><ArticleId IdType="pubmed">28709913</ArticleId></ArticleIdList></Reference><Reference><Citation>Claes S., Myint A.M., Domschke K., Del-Favero J., Entrich K., Engelborghs S., De Deyn P., Mueller N., Baune B., Rothermundt M. The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes. Psychiatry Res. 2011;188:355–360. doi: 10.1016/j.psychres.2011.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2011.03.012</ArticleId><ArticleId IdType="pubmed">21492941</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Budac D.P., Bisulco S., Lee A.W., Smith R.A., Beenders B., Kelley K.W., Dantzer R. NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice. Neuropsychopharmacology. 2013;38:1609–1616. doi: 10.1038/npp.2013.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2013.71</ArticleId><ArticleId IdType="pmc">PMC3717543</ArticleId><ArticleId IdType="pubmed">23511700</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon E., Welle J.R., Woolwine B.J., Goldsmith D.R., Baer W., Patel T., Felger J.C., Miller A.H. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression. Neuropsychopharmacology. 2020;45:998–1007. doi: 10.1038/s41386-020-0607-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-020-0607-1</ArticleId><ArticleId IdType="pmc">PMC7162907</ArticleId><ArticleId IdType="pubmed">31940661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.M., Bao C.H., Wu Y., Liang S.H., Wang D., Wu L.Y., Huang Y., Liu H.R., Wu H.G. Tryptophan-kynurenine metabolism: A link between the gut and brain for depression in inflammatory bowel disease. J. Neuroinflammation. 2021;18:135. doi: 10.1186/s12974-021-02175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02175-2</ArticleId><ArticleId IdType="pmc">PMC8204445</ArticleId><ArticleId IdType="pubmed">34127024</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitz J. The kynurenine pathway: A finger in every pie. Mol. Psychiatr. 2020;25:131–147. doi: 10.1038/s41380-019-0414-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0414-4</ArticleId><ArticleId IdType="pmc">PMC6790159</ArticleId><ArticleId IdType="pubmed">30980044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigner P., Czarny P., Synowiec E., Bijak M., Bialek K., Talarowska M., Galecki P., Szemraj J., Sliwinski T. Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders. J. Cell. Mol. Med. 2018;22:1778–1791. doi: 10.1111/jcmm.13459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13459</ArticleId><ArticleId IdType="pmc">PMC5824396</ArticleId><ArticleId IdType="pubmed">29314569</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K. Etiological classification of depression based on the enzymes of tryptophan metabolism. BMC Psychiatry. 2014;14:372. doi: 10.1186/s12888-014-0372-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-014-0372-y</ArticleId><ArticleId IdType="pmc">PMC4321701</ArticleId><ArticleId IdType="pubmed">25540092</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner J., Walter M., Gos T., Guillemin G.J., Bernstein H.G., Sarnyai Z., Mawrin C., Brisch R., Bielau H., Schwabedissen L.M.Z., et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation. 2011;8:94. doi: 10.1186/1742-2094-8-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-94</ArticleId><ArticleId IdType="pmc">PMC3177898</ArticleId><ArticleId IdType="pubmed">21831269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarcz R., Bruno J.P., Muchowski P.J., Wu H.Q. Kynurenines in the mammalian brain: When physiology meets pathology. Nat. Rev. Neurosci. 2012;13:465–477. doi: 10.1038/nrn3257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3257</ArticleId><ArticleId IdType="pmc">PMC3681811</ArticleId><ArticleId IdType="pubmed">22678511</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonk F., Petit A.C., Abdel-Ahad P., Vinckier F., Jouvion G., de Maricourt P., De Medeiros G.F., Danckaert A., Van Steenwinckel J., Blatzer M., et al. Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine. Brain Behav. Immun. 2019;81:361–373. doi: 10.1016/j.bbi.2019.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.06.033</ArticleId><ArticleId IdType="pubmed">31255681</ArticleId></ArticleIdList></Reference><Reference><Citation>Belleau E.L., Treadway M.T., Pizzagalli D.A. The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology. Biol. Psychiatry. 2019;85:443–453. doi: 10.1016/j.biopsych.2018.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2018.09.031</ArticleId><ArticleId IdType="pmc">PMC6380948</ArticleId><ArticleId IdType="pubmed">30470559</ArticleId></ArticleIdList></Reference><Reference><Citation>Young K.D., Drevets W.C., Dantzer R., Teague T.K., Bodurka J., Savitz J. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav. Immun. 2016;56:335–342. doi: 10.1016/j.bbi.2016.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.04.007</ArticleId><ArticleId IdType="pmc">PMC4917447</ArticleId><ArticleId IdType="pubmed">27091600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q.S., Yan K., Li K.D., Gao L.N., Wang X., Liu H.B., Zhang Z.G., Li K.F., Cui Y.L. Targeting hippocampal phospholipid and tryptophan metabolism for antidepressant-like effects of albiflorin. Phytomedicine. 2021;92:153735. doi: 10.1016/j.phymed.2021.153735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153735</ArticleId><ArticleId IdType="pubmed">34601221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L.B., Wang Y.Y., He Y.X., Zhong H.Q., Ge S.S., Zou Y., Lai Y.S., Xu Q., Gao J., Liu W., et al. Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer. Int. Immunopharmacol. 2022;112:109233. doi: 10.1016/j.intimp.2022.109233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109233</ArticleId><ArticleId IdType="pubmed">36126409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Jaipuri F.A., Waldo J.P., Potturi H., Marcinowicz A., Adams J., Van Allen C., Zhuang H., Vahanian N., Link C., et al. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur. J. Med. Chem. 2020;198:112373. doi: 10.1016/j.ejmech.2020.112373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112373</ArticleId><ArticleId IdType="pubmed">32422549</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R.J., Wang Y.F.Y., Liu D., Luo Q., Du P.X., Zhang H.Y., Wu W.S. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice. Front. Pharmacol. 2022;13:870848. doi: 10.3389/fphar.2022.870848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.870848</ArticleId><ArticleId IdType="pmc">PMC9091350</ArticleId><ArticleId IdType="pubmed">35571116</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Li T.Q., Fang X., Xing Z.K., Zhang S.N., Shi L., Li W.R., Guo L.L., Kuang C.X., Liu H.R., et al. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer. Cancer Lett. 2021;522:32–43. doi: 10.1016/j.canlet.2021.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2021.09.012</ArticleId><ArticleId IdType="pubmed">34520819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirthgen E., Leonard A.K., Scharf C., Domanska G. The Immunomodulator 1-Methyltryptophan Drives Tryptophan Catabolism Toward the Kynurenic Acid Branch. Front. Immunol. 2020;11:313. doi: 10.3389/fimmu.2020.00313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00313</ArticleId><ArticleId IdType="pmc">PMC7059861</ArticleId><ArticleId IdType="pubmed">32180772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis-Ballester A., Pham K.N., Batabyal D., Karkashon S., Bonanno J.B., Poulos T.L., Yeh S.R. Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1. Nat. Commun. 2017;8:1693. doi: 10.1038/s41467-017-01725-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01725-8</ArticleId><ArticleId IdType="pmc">PMC5700043</ArticleId><ArticleId IdType="pubmed">29167421</ArticleId></ArticleIdList></Reference><Reference><Citation>Luke J.J., Tabernero J., Joshua A., Desai J., Varga A.I., Moreno V., Gomez-Roca C.A., Markman B., De Braud F.G., Patel S.P., et al. BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC) J. Clin. Oncol. 2019;37:358. doi: 10.1200/JCO.2019.37.7_suppl.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2019.37.7_suppl.358</ArticleId></ArticleIdList></Reference><Reference><Citation>Reardon D.A., Desjardins A., Rixe O., Cloughesy T., Alekar S., Williams J.H., Li R., Taylor C.T., Lassman A.B. A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma. Investig. New Drugs. 2020;38:1784–1795. doi: 10.1007/s10637-020-00950-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-020-00950-1</ArticleId><ArticleId IdType="pubmed">32436060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.J., Chen Y.C., Huang Y.X., Zhao W.C., Liu Y.H., Venkataramanan R., Lu B.F., Li S. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier. Acta Pharmacol. Sin. 2017;38:823–834. doi: 10.1038/aps.2017.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.44</ArticleId><ArticleId IdType="pmc">PMC5520195</ArticleId><ArticleId IdType="pubmed">28504251</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap T.A., Sahebjam S., Hong D.S., Chiu V.K., Yilmaz E., Efuni S., Grebennik D.O., Collaku A., Ogunmefun E., Liu Y., et al. First-in-human study of KHK2455, a long-acting, potent and selective indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, in combination with mogamulizumab (Moga), an anti-CCR4 monoclonal antibody, in patients (pts) with advanced solid tumors. J. Clin. Oncol. 2018;36:3040. doi: 10.1200/JCO.2018.36.15_suppl.3040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2018.36.15_suppl.3040</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey F.C., Benhadji K.A., Sams L.L., Young D.A., Schindler J.F., Huss K.L., Nikolayev A., Carpenito C., Clawson D., Jones B., et al. Identification and characterization of the IDO1 inhibitor LY3381916. Cancer Res. 2018;78:5245. doi: 10.1158/1538-7445.AM2018-5245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1538-7445.AM2018-5245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>